🇺🇸 FDA
Patent

US 9132122

1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones

granted A61KA61K31/444A61K31/4545

Quick answer

US patent 9132122 (1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones) held by Addex Pharma, S.A. expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/444, A61K31/4545, A61K31/5377, A61K45/06